Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

SANUWAVE Health (SNWV) Research & Development (2016 - 2026)

SANUWAVE Health has reported Research & Development over the past 17 years, most recently at $660000.0 for Q1 2026.

  • Quarterly Research & Development rose 217.31% to $660000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Mar 2026, up 151.39% year-over-year, with the annual reading at $1.4 million for FY2025, 101.04% up from the prior year.
  • Research & Development was $660000.0 for Q1 2026 at SANUWAVE Health, up from $606000.0 in the prior quarter.
  • Over five years, Research & Development peaked at $660000.0 in Q1 2026 and troughed at $73000.0 in Q4 2022.
  • The 5-year median for Research & Development is $165000.0 (2023), against an average of $225352.9.
  • Year-over-year, Research & Development plummeted 58.99% in 2022 and then soared 293.51% in 2025.
  • A 5-year view of Research & Development shows it stood at $73000.0 in 2022, then surged by 95.89% to $143000.0 in 2023, then increased by 7.69% to $154000.0 in 2024, then soared by 293.51% to $606000.0 in 2025, then rose by 8.91% to $660000.0 in 2026.
  • Per Business Quant, the three most recent readings for SNWV's Research & Development are $660000.0 (Q1 2026), $606000.0 (Q4 2025), and $345000.0 (Q3 2025).